| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 6.30e-05 | 14 | 114 | 3 | GO:0004032 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 1.92e-04 | 4 | 114 | 2 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 1.92e-04 | 4 | 114 | 2 | GO:0045703 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 1.92e-04 | 4 | 114 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 1.92e-04 | 4 | 114 | 2 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 3.19e-04 | 5 | 114 | 2 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 3.19e-04 | 5 | 114 | 2 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 3.19e-04 | 5 | 114 | 2 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 3.19e-04 | 5 | 114 | 2 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 3.19e-04 | 5 | 114 | 2 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 3.19e-04 | 5 | 114 | 2 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 3.19e-04 | 5 | 114 | 2 | GO:0047787 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 3.36e-04 | 24 | 114 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 4.28e-04 | 26 | 114 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 4.77e-04 | 6 | 114 | 2 | GO:0045550 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 4.80e-04 | 27 | 114 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 6.58e-04 | 30 | 114 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 6.66e-04 | 7 | 114 | 2 | GO:0072582 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 7.97e-04 | 32 | 114 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 8.85e-04 | 8 | 114 | 2 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 8.85e-04 | 8 | 114 | 2 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 8.85e-04 | 8 | 114 | 2 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 1.13e-03 | 9 | 114 | 2 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 1.13e-03 | 9 | 114 | 2 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 1.41e-03 | 10 | 114 | 2 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 1.41e-03 | 10 | 114 | 2 | GO:0032052 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 2.81e-03 | 14 | 114 | 2 | GO:0001758 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 1.28e-05 | 9 | 112 | 3 | GO:0044597 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 1.82e-05 | 10 | 112 | 3 | GO:0044598 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 1.82e-05 | 10 | 112 | 3 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 1.82e-05 | 10 | 112 | 3 | GO:0030647 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium-mediated signaling | 3.94e-05 | 70 | 112 | 5 | GO:0050850 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 1.74e-04 | 4 | 112 | 2 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 1.74e-04 | 4 | 112 | 2 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 1.74e-04 | 4 | 112 | 2 | GO:0071395 | |
| GeneOntologyBiologicalProcess | positive regulation of protein import | 1.74e-04 | 4 | 112 | 2 | GO:1904591 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 1.74e-04 | 4 | 112 | 2 | GO:0008208 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 2.23e-04 | 22 | 112 | 3 | GO:0016137 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 2.23e-04 | 22 | 112 | 3 | GO:1902644 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 2.89e-04 | 5 | 112 | 2 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 2.89e-04 | 5 | 112 | 2 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 2.89e-04 | 5 | 112 | 2 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 2.89e-04 | 5 | 112 | 2 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 2.89e-04 | 5 | 112 | 2 | GO:0120256 | |
| GeneOntologyBiologicalProcess | regulation of protein import | 2.89e-04 | 5 | 112 | 2 | GO:1904589 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 2.89e-04 | 5 | 112 | 2 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 4.32e-04 | 6 | 112 | 2 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 4.32e-04 | 6 | 112 | 2 | GO:0016095 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 4.85e-04 | 67 | 112 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | regulation of calcium-mediated signaling | 5.20e-04 | 121 | 112 | 5 | GO:0050848 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 6.03e-04 | 7 | 112 | 2 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 6.03e-04 | 7 | 112 | 2 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 6.03e-04 | 7 | 112 | 2 | GO:1900052 | |
| GeneOntologyCellularComponent | anchoring junction | AKAP6 PRICKLE4 FLNC XIRP1 EPPK1 DSG3 ARHGEF5 FBF1 L1CAM OBSL1 AKAP12 DST PTPRC ARHGAP31 AHNAK C19orf84 CDH11 | 1.70e-05 | 976 | 112 | 17 | GO:0070161 |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.52e-04 | 94 | 112 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | Z disc | 1.64e-04 | 151 | 112 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | costamere | 2.14e-04 | 22 | 112 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | I band | 2.74e-04 | 166 | 112 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | cell-cell junction | AKAP6 PRICKLE4 XIRP1 EPPK1 DSG3 FBF1 OBSL1 DST AHNAK C19orf84 CDH11 | 3.34e-04 | 591 | 112 | 11 | GO:0005911 |
| GeneOntologyCellularComponent | intercalated disc | 4.88e-04 | 68 | 112 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | cell-substrate junction | 6.37e-04 | 443 | 112 | 9 | GO:0030055 | |
| GeneOntologyCellularComponent | myofibril | 6.77e-04 | 273 | 112 | 7 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 9.64e-04 | 290 | 112 | 7 | GO:0043292 | |
| GeneOntologyCellularComponent | hemidesmosome | 1.52e-03 | 11 | 112 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | sarcomere | 2.25e-03 | 249 | 112 | 6 | GO:0030017 | |
| GeneOntologyCellularComponent | focal adhesion | 2.25e-03 | 431 | 112 | 8 | GO:0005925 | |
| Domain | ZnF_C2HC | FAM90A14 RBBP6 FAM90A1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A10 | 9.34e-10 | 55 | 108 | 8 | SM00343 |
| Domain | Znf_CCHC | FAM90A14 RBBP6 FAM90A1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A10 | 9.34e-10 | 55 | 108 | 8 | IPR001878 |
| Domain | NUT | 5.26e-09 | 5 | 108 | 4 | IPR024310 | |
| Domain | NUT_N | 5.26e-09 | 5 | 108 | 4 | IPR024309 | |
| Domain | NUT | 5.26e-09 | 5 | 108 | 4 | PF12881 | |
| Domain | ALDOKETO_REDUCTASE_1 | 2.19e-05 | 10 | 108 | 3 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 2.19e-05 | 10 | 108 | 3 | IPR018170 | |
| Domain | Aldo/keto_reductase | 2.19e-05 | 10 | 108 | 3 | IPR020471 | |
| Domain | ALDOKETO_REDUCTASE_2 | 2.19e-05 | 10 | 108 | 3 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 2.19e-05 | 10 | 108 | 3 | PS00063 | |
| Domain | ARHGEF5_35 | 3.31e-05 | 2 | 108 | 2 | PF15441 | |
| Domain | ARHGEF5/35_N | 3.31e-05 | 2 | 108 | 2 | IPR029212 | |
| Domain | - | 9.97e-05 | 16 | 108 | 3 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 1.21e-04 | 17 | 108 | 3 | IPR023210 | |
| Domain | Aldo_ket_red | 1.21e-04 | 17 | 108 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 1.21e-04 | 17 | 108 | 3 | IPR001395 | |
| Domain | PET | 4.89e-04 | 6 | 108 | 2 | PF06297 | |
| Domain | - | 4.89e-04 | 6 | 108 | 2 | 3.90.1290.10 | |
| Domain | PET_domain | 4.89e-04 | 6 | 108 | 2 | IPR010442 | |
| Domain | PET | 4.89e-04 | 6 | 108 | 2 | PS51303 | |
| Domain | Plectin_repeat | 6.83e-04 | 7 | 108 | 2 | IPR001101 | |
| Domain | Plectin | 6.83e-04 | 7 | 108 | 2 | PF00681 | |
| Domain | PLEC | 6.83e-04 | 7 | 108 | 2 | SM00250 | |
| Domain | FN3 | 4.43e-03 | 185 | 108 | 5 | SM00060 | |
| Domain | - | 5.88e-03 | 20 | 108 | 2 | 3.30.565.10 | |
| Domain | GPCR_3 | 6.48e-03 | 21 | 108 | 2 | IPR000337 | |
| Domain | HATPase_C | 6.48e-03 | 21 | 108 | 2 | IPR003594 | |
| Domain | 7tm_3 | 7.10e-03 | 22 | 108 | 2 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 7.10e-03 | 22 | 108 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 7.10e-03 | 22 | 108 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 7.10e-03 | 22 | 108 | 2 | PS00979 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 7.01e-06 | 9 | 63 | 3 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 7.01e-06 | 9 | 63 | 3 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 1.37e-05 | 11 | 63 | 3 | M47812 | |
| Pubmed | FAM90A14 FAM90A2P FAM90A1 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 2.25e-26 | 25 | 119 | 13 | 17684299 | |
| Pubmed | FAM90A14 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 6.12e-22 | 23 | 119 | 11 | 18602769 | |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | FAM90A14 FAM90A1 FAM90A17 FAM90A19 FAM90A22 FAM90A26 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A10 | 1.24e-11 | 164 | 119 | 11 | 22967998 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RBBP6 SMCHD1 HNRNPM HLCS TACC2 GPKOW NSRP1 AKAP12 UBE2O SAFB DST MTHFD1 AHNAK EIF4B NCOA7 EIF3G TOP2A AHNAK2 | 3.25e-09 | 934 | 119 | 18 | 33916271 |
| Pubmed | FLNC UBA2 GPKOW NSRP1 AKAP12 SAFB GANAB DST AHNAK SRRM2 TIMM44 AHNAK2 | 4.43e-09 | 360 | 119 | 12 | 33111431 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.70e-08 | 130 | 119 | 8 | 35545047 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPPK1 SMCHD1 HNRNPM UBA2 RNF213 SAFB MTHFD1 AHNAK SRRM2 TOP2A AHNAK2 | 2.14e-08 | 332 | 119 | 11 | 32786267 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | FLNC SMCHD1 HNRNPM TACC2 ZHX2 GPKOW SAFB AHNAK EIF4B EIF3G TOP2A AHNAK2 | 4.48e-08 | 444 | 119 | 12 | 34795231 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | ACAP1 EPPK1 RBBP6 HNRNPM OBSL1 NSRP1 SAFB GANAB DST MTHFD1 AHNAK EIF4B CPSF1 SRRM2 TOP2A | 9.16e-07 | 949 | 119 | 15 | 36574265 |
| Pubmed | 1.15e-06 | 225 | 119 | 8 | 12168954 | ||
| Pubmed | ARHGAP23 RBBP6 FBF1 HNRNPM OBSL1 HLCS RNF213 C16orf96 NSRP1 INTS10 UBR5 RCOR3 DNA2 SRRM2 TOP2A SLC39A7 | 1.38e-06 | 1116 | 119 | 16 | 31753913 | |
| Pubmed | RBBP6 HNRNPM WASHC2A GPKOW NSRP1 UBE2O DST INF2 MTHFD1 CPSF1 SRRM2 | 1.42e-06 | 506 | 119 | 11 | 30890647 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNC EPPK1 HNRNPM UBA2 AKR1A1 AKAP12 UBE2O GANAB DST UBR5 MTHFD1 AHNAK EIF4B NEMF EIF3G SRRM2 | 2.01e-06 | 1149 | 119 | 16 | 35446349 |
| Pubmed | SETD1A RBBP6 SMCHD1 OBSL1 AHNAK PRDM12 RCOR3 EIF3G DNA2 TOP2A | 5.19e-06 | 469 | 119 | 10 | 27634302 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | SETD1A SGSM1 FBF1 UBA2 NUTM2D WASHC2A GALNT18 INKA2 NUTM2G NUTM2E SLC38A10 NUTM2B CRACDL KDM7A ECI2 NUTM2F | 5.40e-06 | 1242 | 119 | 16 | 30973865 |
| Pubmed | 5.75e-06 | 74 | 119 | 5 | 35102251 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 6.02e-06 | 477 | 119 | 10 | 31300519 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPPK1 SMCHD1 HNRNPM TACC2 UBE2O GANAB UBR5 MTHFD1 AHNAK EIF4B NEMF ECI2 EIF3G SRRM2 TIMM44 TOP2A AHNAK2 | 6.72e-06 | 1415 | 119 | 17 | 28515276 |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 8573067 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 11514561 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15492289 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 16229975 | ||
| Pubmed | cDNA and deduced amino acid sequences of a human colon dihydrodiol dehydrogenase. | 1.16e-05 | 2 | 119 | 2 | 8011662 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15007166 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 20833135 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 18654764 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21217827 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 26934124 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 8486699 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 10921916 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | EPPK1 FBF1 HNRNPM OBSL1 FAM117B FAM90A1 GALNT18 AKAP12 UBR5 SRRM2 TIMM44 | 1.30e-05 | 639 | 119 | 11 | 23443559 |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 1.55e-05 | 231 | 119 | 7 | 36597993 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETD1A FLNC ARHGAP23 SMCHD1 HNRNPM SAFB DST UBR5 INF2 MTHFD1 AHNAK CPSF1 SRRM2 TIMM44 TOP2A AHNAK2 | 1.56e-05 | 1353 | 119 | 16 | 29467282 |
| Pubmed | RGPD4 EPPK1 RBBP6 SMCHD1 HNRNPM SAFB GANAB AHNAK CPSF1 SRRM2 TOP2A | 1.56e-05 | 652 | 119 | 11 | 31180492 | |
| Pubmed | 1.70e-05 | 538 | 119 | 10 | 28524877 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNC EMC7 EPPK1 HNRNPM RNF213 AKR1A1 GPKOW AKAP12 UBE2O SAFB INF2 AHNAK EIF4B EIF3G TOP2A AHNAK2 | 1.77e-05 | 1367 | 119 | 16 | 32687490 |
| Pubmed | 2.58e-05 | 250 | 119 | 7 | 33536335 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 19320734 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 3.47e-05 | 3 | 119 | 2 | 31780644 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 22456610 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 11564800 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 19843512 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 21232532 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 9148925 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 13678667 | ||
| Pubmed | Interleukin 1β regulates progesterone metabolism in human cervical fibroblasts. | 3.47e-05 | 3 | 119 | 2 | 22064385 | |
| Pubmed | Filamin C is a highly dynamic protein associated with fast repair of myofibrillar microdamage. | 3.47e-05 | 3 | 119 | 2 | 27206985 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 9324357 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 23115302 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 10510318 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 24963132 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 21940993 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 19151983 | ||
| Pubmed | The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney. | 3.47e-05 | 3 | 119 | 2 | 26542179 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 3.59e-05 | 361 | 119 | 8 | 26167880 | |
| Pubmed | EMC7 EPPK1 RBBP6 SMCHD1 L1CAM AKAP12 GANAB DST UBR5 MTHFD1 AHNAK EIF4B NEMF SRRM2 SLC39A7 | 3.80e-05 | 1297 | 119 | 15 | 33545068 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 4.01e-05 | 268 | 119 | 7 | 33024031 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 TACC2 WASHC2A GPKOW AKAP12 GANAB UBR5 INF2 AHNAK EIF4B RCOR3 CEP152 EIF3G TOP2A | 4.24e-05 | 1155 | 119 | 14 | 20360068 |
| Pubmed | RBBP6 SMCHD1 UBA2 RNF213 GPKOW AKR1C1 AKR1C2 SAFB UBR5 AHNAK CPSF1 EIF3G TOP2A | 4.60e-05 | 1014 | 119 | 13 | 32416067 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNC EPPK1 SMCHD1 OBSL1 SAFB GANAB DST UBR5 MTHFD1 AHNAK CPSF1 SRRM2 TOP2A | 5.08e-05 | 1024 | 119 | 13 | 24711643 |
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 5.13e-05 | 59 | 119 | 4 | 16083285 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 20124700 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 6.93e-05 | 4 | 119 | 2 | 10500239 | |
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 6.93e-05 | 4 | 119 | 2 | 16508162 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 6.93e-05 | 4 | 119 | 2 | 14967952 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 6.93e-05 | 4 | 119 | 2 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 6.93e-05 | 4 | 119 | 2 | 31479646 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 23281368 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 15222881 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 16191478 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 15577209 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 17185750 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 10702227 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 17034817 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 17629694 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 6.93e-05 | 4 | 119 | 2 | 29764944 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 10526179 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 17888864 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 17442338 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 28329705 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 16018803 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 17272929 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 19237748 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 6.93e-05 | 4 | 119 | 2 | 18667791 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 28259989 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 21521174 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 8274401 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 16511129 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 6.93e-05 | 4 | 119 | 2 | 34590152 | |
| Pubmed | Differential requirements for CD45 in NK-cell function reveal distinct roles for Syk-family kinases. | 6.93e-05 | 4 | 119 | 2 | 21245479 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 7789999 | ||
| Pubmed | 7.24e-05 | 399 | 119 | 8 | 35987950 | ||
| Pubmed | 7.50e-05 | 24 | 119 | 3 | 19616115 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RGPD4 EPPK1 HNRNPM AKAP12 GANAB UBR5 MTHFD1 AHNAK ECI2 TOP2A | 8.01e-05 | 647 | 119 | 10 | 26618866 |
| Pubmed | FGF11 induced by hypoxia interacts with HIF-1α and enhances its stability. | 8.15e-05 | 128 | 119 | 5 | 28027390 | |
| Pubmed | 8.64e-05 | 653 | 119 | 10 | 33742100 | ||
| Pubmed | 8.64e-05 | 653 | 119 | 10 | 22586326 | ||
| Interaction | SUMO2 interactions | ANKRD35 EPPK1 SMCHD1 HNRNPM UBA2 RNF213 SAFB DST MTHFD1 AHNAK RCOR3 SRRM2 TOP2A AHNAK2 | 2.35e-06 | 591 | 105 | 14 | int:SUMO2 |
| Interaction | NAA40 interactions | RBBP6 SMCHD1 HNRNPM HLCS TACC2 GPKOW NSRP1 AKAP12 UBE2O SAFB DST MTHFD1 AHNAK EIF4B NCOA7 EIF3G TOP2A AHNAK2 | 2.81e-06 | 978 | 105 | 18 | int:NAA40 |
| Interaction | ARHGEF35 interactions | 1.13e-05 | 9 | 105 | 3 | int:ARHGEF35 | |
| Interaction | FAM90A26 interactions | 2.69e-05 | 2 | 105 | 2 | int:FAM90A26 | |
| Interaction | SLFN11 interactions | BDP1 RBBP6 HNRNPM RNF213 EIF4B CPSF1 NUTM2F DNA2 SRRM2 TOP2A | 2.71e-05 | 376 | 105 | 10 | int:SLFN11 |
| Interaction | FGF11 interactions | 3.05e-05 | 170 | 105 | 7 | int:FGF11 | |
| Interaction | PINK1 interactions | FLNC EPPK1 DSG3 HNRNPM AKR1C2 UBE2O GANAB DST MTHFD1 AHNAK EIF4B SRRM2 AHNAK2 | 5.20e-05 | 679 | 105 | 13 | int:PINK1 |
| Interaction | CIT interactions | ANKRD35 GPRASP1 FLNC EPPK1 RBBP6 SMCHD1 HNRNPM OBSL1 RNF213 AKR1A1 SAFB GANAB INF2 AHNAK CPSF1 ECI2 SRRM2 TOP2A SLC39A7 AHNAK2 | 5.21e-05 | 1450 | 105 | 20 | int:CIT |
| Interaction | ACTC1 interactions | RBBP6 HNRNPM OBSL1 WASHC2A GPKOW NSRP1 UBE2O DST INF2 MTHFD1 CPSF1 NUTM2F SRRM2 | 6.49e-05 | 694 | 105 | 13 | int:ACTC1 |
| Cytoband | 8p23.1 | FAM90A14 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 9.15e-15 | 154 | 119 | 12 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A14 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.36e-12 | 234 | 119 | 12 | chr8p23 |
| Cytoband | 19p13.3-p13.2 | 6.05e-06 | 14 | 119 | 3 | 19p13.3-p13.2 | |
| Cytoband | 10p15-p14 | 9.93e-05 | 6 | 119 | 2 | 10p15-p14 | |
| Cytoband | 19p13.12 | 3.04e-04 | 50 | 119 | 3 | 19p13.12 | |
| Cytoband | 10q23.2 | 8.83e-04 | 17 | 119 | 2 | 10q23.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q22 | 1.88e-03 | 200 | 119 | 4 | chr9q22 | |
| GeneFamily | Aldo-keto reductases | 2.05e-05 | 15 | 66 | 3 | 399 | |
| GeneFamily | G protein-coupled receptors, Class C orphans | 2.72e-04 | 7 | 66 | 2 | 285 | |
| GeneFamily | EF-hand domain containing|Plakins | 3.62e-04 | 8 | 66 | 2 | 939 | |
| GeneFamily | RNA binding motif containing | 1.08e-03 | 213 | 66 | 5 | 725 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.84e-08 | 197 | 108 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.95e-08 | 198 | 108 | 8 | fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.95e-08 | 198 | 108 | 8 | 22935a8afac54021f68b5f7a5accf51523e2f336 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.61e-07 | 186 | 108 | 7 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.32e-07 | 197 | 108 | 7 | 233b9fcb376e08d0080a05ca0198ecc6ec720f90 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.32e-07 | 197 | 108 | 7 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-07 | 199 | 108 | 7 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 3.71e-06 | 170 | 108 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-06 | 175 | 108 | 6 | 3bca1aac2a2a1f46753b5f9462888f144ed8327b | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 5.31e-06 | 181 | 108 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 5.48e-06 | 182 | 108 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 5.84e-06 | 184 | 108 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 6.40e-06 | 187 | 108 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.40e-06 | 187 | 108 | 6 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.45e-06 | 192 | 108 | 6 | b016e229300c183e14c0e2bba494bf49c7899112 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-06 | 192 | 108 | 6 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.45e-06 | 192 | 108 | 6 | ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 194 | 108 | 6 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.90e-06 | 194 | 108 | 6 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.14e-06 | 195 | 108 | 6 | 24d226f89dd337c22728688e4b40ca082a0e1fe1 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 8.38e-06 | 196 | 108 | 6 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.38e-06 | 196 | 108 | 6 | 36b4f08fc038dfde6343ff0869e1a027d882adb5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.62e-06 | 197 | 108 | 6 | 1d4ccca2ff46fccb3ac052b5148cb7f94231d65a | |
| ToppCell | 3'-Broncho-tracheal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.62e-06 | 197 | 108 | 6 | 5d33f8a6940431093e927b186fb9b630a89d8ec1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.87e-06 | 198 | 108 | 6 | 89ec1e760a193441092571475cc66a3b425f232e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.87e-06 | 198 | 108 | 6 | 240e1aa0594ee6de530b2f97d5e392c5fcbf278b | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.87e-06 | 198 | 108 | 6 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.87e-06 | 198 | 108 | 6 | aa6e7218ee6230902854e66c444b544218b30c0e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.87e-06 | 198 | 108 | 6 | 9a229167d4da4abf8c336dfe5cfdf57db756fc8b | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.87e-06 | 198 | 108 | 6 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.13e-06 | 199 | 108 | 6 | 4099df3c052a9536d72ba01492317be7d83a79ad | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.13e-06 | 199 | 108 | 6 | c88a28a73f54dc571f2ff1e4b55073f83cbead2c | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.40e-06 | 200 | 108 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.96e-05 | 135 | 108 | 5 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.91e-05 | 170 | 108 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.60e-05 | 174 | 108 | 5 | 59ccc5a82507463e0a316ba6286cb25ec1a4091b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-05 | 175 | 108 | 5 | f7d191cde68de8f3457fa62b1df53b6d0dbe5001 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.96e-05 | 176 | 108 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 177 | 108 | 5 | f6b9d91d46830d0d207b0abd4ee5a4942fd99774 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-05 | 182 | 108 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c13-HAVCR2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.16e-05 | 182 | 108 | 5 | 6c9a48037fa002bc528875538bdaaf15696d68b6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.37e-05 | 183 | 108 | 5 | 764ea07621f77fbd13a877aed5806ae2b3dfb43e | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.37e-05 | 183 | 108 | 5 | 79defd22b3194dad16db55b9bdd220c09c1e6b90 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 8.37e-05 | 183 | 108 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.37e-05 | 183 | 108 | 5 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | (6)_Endothelial-F_(Lymphatics)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.59e-05 | 184 | 108 | 5 | 03ea613e00b45c81b752c14505a0538d698f551e | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.59e-05 | 184 | 108 | 5 | 1a4297b9d3cc4744bea0408fd5ee7b33ba2a1d78 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.81e-05 | 185 | 108 | 5 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 185 | 108 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.81e-05 | 185 | 108 | 5 | e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.81e-05 | 185 | 108 | 5 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 186 | 108 | 5 | f23f21781a758541f59c06efa7739d26a03fb478 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.04e-05 | 186 | 108 | 5 | 18fd311252299d6d30ddb32002ed069056108206 | |
| ToppCell | COVID_vent-Myeloid-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 9.04e-05 | 186 | 108 | 5 | 63a5cdd3f60681762a218be32db84be8f29b88fd | |
| ToppCell | COVID_vent-Myeloid-Dendritic-cDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 9.04e-05 | 186 | 108 | 5 | 39457a7b43537f2c3e221f9375c95d4515424d7d | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 186 | 108 | 5 | 0de87109da9324c597fadf2eb782f0f158afe832 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 9.27e-05 | 187 | 108 | 5 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.50e-05 | 188 | 108 | 5 | aa69e3f44d506f5ef358a3374ac5160d847c858f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.50e-05 | 188 | 108 | 5 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.50e-05 | 188 | 108 | 5 | 1f40b959777d18ad88d239df8cca304f062ba04c | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.74e-05 | 189 | 108 | 5 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-05 | 189 | 108 | 5 | 4dc32b463546bbe7250dddd281b92ad17ec22da1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-05 | 189 | 108 | 5 | 0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 9.74e-05 | 189 | 108 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 9.99e-05 | 190 | 108 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.99e-05 | 190 | 108 | 5 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.99e-05 | 190 | 108 | 5 | b2bd2cb384bb8a5662064ed1aee68e905e1f780d | |
| ToppCell | (4)_Endothelial_cells-(40)_EC-arterial|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 9.99e-05 | 190 | 108 | 5 | ff774faf3f12759d11e50ed7d189288bb79e22e1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.99e-05 | 190 | 108 | 5 | a5db902ad112a0c0a0a7f1a2e38718bb3bd11412 | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.99e-05 | 190 | 108 | 5 | 103e78c2233c3ee0c215a9dafe70705477e9ee5e | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-04 | 191 | 108 | 5 | f5ce33af56178333730be308253943c54a0724cf | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.05e-04 | 192 | 108 | 5 | 02b11233b4da2d85b96498b3c6e22e3a31b3d049 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 193 | 108 | 5 | 173f1d83133f5ffa88e2a75d28835ad7acd2aa90 | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.07e-04 | 193 | 108 | 5 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 193 | 108 | 5 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | BL-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.10e-04 | 194 | 108 | 5 | 2932f704656ca368565ec12f3452af3b18e8df12 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.10e-04 | 194 | 108 | 5 | 297286c57d7ee6338d9cf77b27eb2809378ce15d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 194 | 108 | 5 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.13e-04 | 195 | 108 | 5 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-04 | 197 | 108 | 5 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-04 | 197 | 108 | 5 | 3332b9b5bf78f0203ebbd94257a36e9054d896c3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-04 | 197 | 108 | 5 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 1.18e-04 | 197 | 108 | 5 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.18e-04 | 197 | 108 | 5 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.18e-04 | 197 | 108 | 5 | 08b371309cd790b171ed76cabc7d910e71cd2835 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.18e-04 | 197 | 108 | 5 | 9f49feee38647bbf964974aac96fa75602186b5c | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-04 | 197 | 108 | 5 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 198 | 108 | 5 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-04 | 198 | 108 | 5 | 3371276410dba693c238b383d990b89371b14d8d | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 198 | 108 | 5 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | PSB-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-04 | 198 | 108 | 5 | e4cbe4032dba0da3fd46817ea9ad86ba9217f747 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-04 | 198 | 108 | 5 | 4a481e1edb80b950c823ed926842cd5132cfb27f | |
| ToppCell | 5'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-04 | 198 | 108 | 5 | 90e85fe7a0ab376a41666dfff6c0e95b7f1c9475 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 198 | 108 | 5 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | 10x_5'_v1|World / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-04 | 199 | 108 | 5 | 0478eafaa2a4819d1bbfb227e6c00d3578429bed | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-04 | 199 | 108 | 5 | a255484ba77bd2741a541da278efc8cf4abbe570 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-04 | 200 | 108 | 5 | 41705bbba40eb5ddca0b223191aac1bce00163b8 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-04 | 200 | 108 | 5 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.27e-04 | 200 | 108 | 5 | 53e04399d0308b40ae99fbfaa4ff62bf061822d8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.27e-04 | 200 | 108 | 5 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| Drug | o-quinone | 1.37e-06 | 41 | 107 | 5 | CID000011421 | |
| Drug | 9,10-phenanthrenequinone | 5.40e-06 | 25 | 107 | 4 | ctd:C005399 | |
| Drug | 4-hydroxybenzoic acid | 8.30e-06 | 9 | 107 | 3 | ctd:C038193 | |
| Drug | Dihydroxydihydrobenzopyrenes | 1.62e-05 | 11 | 107 | 3 | ctd:D004101 | |
| Drug | fenamic acid | 2.15e-05 | 12 | 107 | 3 | ctd:C001209 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 2.19e-05 | 2 | 107 | 2 | DB07768 | |
| Drug | 4-formyl-benzoate | 2.79e-05 | 13 | 107 | 3 | CID000012088 | |
| Drug | 1-acenaphthenol | 3.54e-05 | 14 | 107 | 3 | CID000022750 | |
| Drug | benzo(a)pyrene-1,6-quinone | 6.54e-05 | 17 | 107 | 3 | ctd:C030233 | |
| Drug | cyclopentanone | 6.54e-05 | 3 | 107 | 2 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 6.54e-05 | 3 | 107 | 2 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 6.54e-05 | 3 | 107 | 2 | ctd:C058818 | |
| Drug | cyclopentanol | 6.54e-05 | 3 | 107 | 2 | ctd:C016327 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 6.54e-05 | 3 | 107 | 2 | ctd:C530610 | |
| Disease | Neoplasms, Hormone-Dependent | 3.14e-05 | 3 | 96 | 2 | C0027661 | |
| Disease | Ambiguous Genitalia | 1.04e-04 | 5 | 96 | 2 | C0266362 | |
| Disease | Pseudohermaphroditism | 1.04e-04 | 5 | 96 | 2 | C0033804 | |
| Disease | Endometrial Stromal Sarcoma | 1.04e-04 | 5 | 96 | 2 | C0206630 | |
| Disease | Hermaphroditism | 1.04e-04 | 5 | 96 | 2 | C0019269 | |
| Disease | Intersex Conditions | 1.04e-04 | 5 | 96 | 2 | C2930618 | |
| Disease | Sex Differentiation Disorders | 1.04e-04 | 5 | 96 | 2 | C2930619 | |
| Disease | Clear cell sarcoma of kidney | 1.56e-04 | 6 | 96 | 2 | C0334488 | |
| Disease | Disorders of Sex Development | 2.18e-04 | 7 | 96 | 2 | C0036875 | |
| Disease | cancer (implicated_via_orthology) | 2.48e-04 | 268 | 96 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | X-Linked Csnb | 6.77e-04 | 12 | 96 | 2 | C3711543 | |
| Disease | Night blindness, congenital stationary, type 1 | 6.77e-04 | 12 | 96 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 6.77e-04 | 12 | 96 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 6.77e-04 | 12 | 96 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 6.77e-04 | 12 | 96 | 2 | C1848172 | |
| Disease | cleft palate (is_implicated_in) | 6.77e-04 | 12 | 96 | 2 | DOID:674 (is_implicated_in) | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 6.77e-04 | 12 | 96 | 2 | C1850362 | |
| Disease | hematologic cancer (implicated_via_orthology) | 7.98e-04 | 13 | 96 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 7.98e-04 | 13 | 96 | 2 | C4041558 | |
| Disease | cutaneous melanoma, hair color | 1.10e-03 | 62 | 96 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | response to methotrexate | 1.22e-03 | 16 | 96 | 2 | GO_0031427 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 1.22e-03 | 16 | 96 | 2 | C0334634 | |
| Disease | Sclerocystic Ovaries | 1.28e-03 | 144 | 96 | 4 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 1.28e-03 | 144 | 96 | 4 | C0032460 | |
| Disease | Night blindness, congenital stationary | 1.38e-03 | 17 | 96 | 2 | C0339535 | |
| Disease | chromosomal aberration frequency | 1.55e-03 | 18 | 96 | 2 | EFO_0009860 | |
| Disease | Brugada syndrome | 1.73e-03 | 19 | 96 | 2 | MONDO_0015263 | |
| Disease | Seckel syndrome | 2.32e-03 | 22 | 96 | 2 | C0265202 | |
| Disease | Left ventricular mass to end-diastolic volume ratio | 2.99e-03 | 25 | 96 | 2 | EFO_0010556 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEKPGNEPEEVKLQN | 6 | P0CW23 | |
| KNGPEEVKPLGEVET | 941 | A6H8Y1 | |
| KSQGLDVQEPPVKDG | 1551 | O94986 | |
| GEKEKLPGELEPVQA | 191 | O75821 | |
| KKRPDGKQEQAPVED | 816 | Q02952 | |
| EKGVPVSGQEAKEPE | 366 | Q12774 | |
| EKGVPVSGQEAKEPE | 366 | A5YM69 | |
| EVPDVNIEGPEGKLK | 916 | Q09666 | |
| KGEGPDVDVNLPKAD | 3036 | Q09666 | |
| DVPDVNIEGPEGKLK | 3061 | Q09666 | |
| GPEVDIKGPKVDINA | 3776 | Q09666 | |
| KGEGPEVDVNLPKAD | 3946 | Q09666 | |
| KGEGPDVDVNLPKAD | 4666 | Q09666 | |
| TLPAQDGKKEARGPE | 156 | I3L1E1 | |
| KQKELGGEEPEPSLR | 246 | Q15027 | |
| DEEKEKRVPGARGEP | 581 | Q8N283 | |
| QDSGELDKGQGPPKE | 1316 | O14529 | |
| ANPGPLNKDKGEKEE | 91 | A6NDY2 | |
| EGGIEEFKPPESNQK | 271 | Q9P2K3 | |
| GQEKGKEQERPPEAV | 506 | Q9H0G5 | |
| ANPGPLNKDKGEKEE | 91 | A6NKC0 | |
| PIQDGGKSQEEPSKV | 526 | Q9NVR2 | |
| EKEGPQPQEKPVGAL | 571 | A6NDB9 | |
| QPQEKPVGALEEEGV | 576 | A6NDB9 | |
| GEELKSNEPEGQVEP | 651 | O75147 | |
| LGVDGEGKEVQPPSK | 861 | P32926 | |
| ANPGPLNKDKGEKEE | 91 | A8MXZ1 | |
| EEENGKPVKSQGIPI | 476 | Q6ZMT4 | |
| GDVNVEKNETEPPKG | 426 | O60524 | |
| PDIKGDQKENPGGQE | 731 | O60721 | |
| GAREPKGEKGQPQEL | 186 | Q9NTI7 | |
| EKPEGQIQKQEAVGP | 1636 | Q6PRD1 | |
| ANPGPLNKDKGEKEE | 91 | Q86YD7 | |
| KTPVLPERAKEENGG | 1091 | Q5T848 | |
| QGVQPKTGPFEDLKE | 111 | P43405 | |
| SEQKPVGGDPKAIEI | 6401 | Q03001 | |
| KENLEKPRSPGEVTG | 586 | Q5HYC2 | |
| PKGEGERPAQNEKRK | 36 | P52272 | |
| VGRDDPKALGEEPKQ | 61 | P50747 | |
| QERAKDAEKPAEVPG | 231 | Q9HBU1 | |
| PVRKEEEDNPKGEGT | 541 | Q10570 | |
| ANPGPLNKDKGEKEE | 91 | A8MWA6 | |
| ANPGPLNKDKGEKEE | 91 | P0C7W9 | |
| PKGTEEPVKVREAGD | 516 | Q14315 | |
| EKDKEDQPQGLVPGG | 231 | Q92917 | |
| EAAPEKNPVDVKGEG | 711 | P32004 | |
| GTPKGVGPVKENDEI | 191 | Q6P587 | |
| GIPGVPGLEEDQKKN | 211 | Q9H4Q4 | |
| ANPGPLNKDKGEKEE | 91 | P0DV74 | |
| ANPGPLNKDKGEKEE | 91 | P0DV73 | |
| PDPDVLEKREKQAGE | 236 | Q96M63 | |
| EPGKQAKVPERGQEP | 856 | Q6NV74 | |
| AKVPERGQEPVKQAD | 861 | Q6NV74 | |
| ANPGPLNKDKGEKEE | 91 | P0DV76 | |
| DGKPVRKGPGKQEEV | 956 | Q27J81 | |
| ELAKGQGPGEVDPKV | 121 | P17568 | |
| GLPKEEGKQQEKPEG | 206 | Q9NZU5 | |
| KPAKGPQEKVDGERE | 1036 | Q7Z6E9 | |
| NRPGDKAEAPKGQEQ | 271 | Q2TBC4 | |
| ANPGPLNKDKGEKEE | 91 | A6NJQ4 | |
| PKAEKRQIGDQEGPR | 221 | Q8TES7 | |
| KPETDRVPGDGGQKE | 221 | Q0VDD7 | |
| DRVGKDGAPKEAQPK | 541 | A6NNT2 | |
| IPPIKSAQGEGDDVK | 1576 | Q8TD84 | |
| GEKEEQLIPQDIPDG | 361 | Q6P1L5 | |
| RGKVLQPPKGDVAAE | 216 | Q86VU5 | |
| VRGQEPAPDKKLEED | 41 | Q6P9A2 | |
| AVPGEEVGRVKAKDP | 281 | P55287 | |
| PGNKGREFVPDEQKQ | 221 | Q96JA4 | |
| TDIPPGGVEEKAKNN | 206 | O75521 | |
| KIEGRAVVPGVKPQD | 46 | Q9NPA0 | |
| LNPKEPGKRDGEGQE | 4371 | Q8NDH2 | |
| GEGVQESKKEPGVVP | 4926 | Q8NDH2 | |
| ANPGPLNKDKGEKEE | 91 | A6NIJ5 | |
| NTDKVPAPEQVEKGG | 896 | P51530 | |
| ANPGPLNKDKGEKEE | 91 | A8MXJ8 | |
| EGEPDSAKNVQLKPG | 66 | Q9P1V8 | |
| REEEKERQQAPGGDP | 451 | Q9UMX9 | |
| QAQIKGPVDVPGRED | 456 | Q9HBR0 | |
| VPDDKKPNGRKVVGD | 241 | P11586 | |
| ANPGPLNKDKGEKEE | 91 | P0C7X0 | |
| QPSEEGPGRKDENKV | 516 | P23588 | |
| GEPEKQREEGEVKQP | 536 | Q8IVF1 | |
| GEPEKQREEGKVKQP | 536 | A6NNL0 | |
| PEKQREEGEVKQPQE | 466 | Q5VT03 | |
| GEPEKQREEGKVKQP | 536 | B1AL46 | |
| PEGQREKGKVEQPQE | 416 | A1L443 | |
| PEGQREKGKVEQPQE | 401 | Q5VZR2 | |
| KKPGEEVVGGAEIEN | 16 | Q5JY77 | |
| EEAEKNPVGKARKEP | 1776 | Q2WGJ9 | |
| GISEPGNQEKESEKP | 926 | Q7Z3J3 | |
| GPKGNEIRTSKEVEP | 356 | A6NHR9 | |
| KDVNPGGKEETPGQR | 101 | Q9UQ35 | |
| PKEDQNGLVDPKTRG | 896 | Q8WUY3 | |
| ANEKAPVEGIGQPEK | 136 | Q8WW59 | |
| QAGDPITEGNKEPDK | 566 | Q8NI08 | |
| ANPGPLNKDKGEKEE | 91 | A8MX19 | |
| PEETQGKAEKDEPGA | 211 | Q14697 | |
| ANPGPLNKDKGEKEE | 91 | A6NNJ1 | |
| ANPGPLNKDKGEKEE | 91 | P0C7W8 | |
| ANPGPLNKDKGEKEE | 91 | D6RGX4 | |
| GVLVPAKDQPGRQEK | 4896 | P58107 | |
| VVGDAPEKVGPKQAE | 546 | Q9UBT2 | |
| GDVPGVPQKREAEET | 3776 | Q9P2P6 | |
| QDKPEVDKGEGQLPE | 296 | Q96LA9 | |
| EQEKEAGEPGRPGTK | 926 | O15047 | |
| ANPGPLNKDKGEKEE | 91 | P0C7V4 | |
| KGRKPEEEGVEDNGL | 91 | Q15424 | |
| AVVKREPAEQPGDGE | 291 | Q15424 | |
| NGNIEGIPERQKGKP | 1896 | Q13023 | |
| EVQAGQVDVKLPEGP | 891 | Q8IVF2 | |
| EVQAGQVDVKLPEGP | 1551 | Q8IVF2 | |
| EVQAGQVDVKLPEGP | 2376 | Q8IVF2 | |
| EVQAGQVDVKLPEGP | 2541 | Q8IVF2 | |
| EVQAGQVDVKLPEGP | 4026 | Q8IVF2 | |
| EVQAGQVDVKLPEGP | 4191 | Q8IVF2 | |
| EVQAGQEDVKLPEGP | 4356 | Q8IVF2 | |
| KEDVGPGKAVPREEL | 61 | P14550 | |
| SVKPGEEVIPKDENG | 121 | Q04828 | |
| SVKPGEEVIPKDENG | 121 | P52895 | |
| NEQGEPEDLKKPEGK | 331 | Q63HN8 | |
| PKDGPVRPQNAEEEK | 296 | Q92504 | |
| DPIQAEQPELREKKG | 26 | Q9Y458 | |
| EDKGERTPVGDKEPQ | 1101 | Q9P227 | |
| ANPGPLNKDKGEKEE | 91 | Q658T7 | |
| AVPDVERKEDKPEGQ | 881 | Q9C0C9 | |
| PSAGRERQPKEEGQK | 171 | O95359 | |
| ELEKRPNPEKVVEEG | 601 | Q2M1Z3 | |
| PNPEKVVEEGREAGE | 606 | Q2M1Z3 | |
| EAEGRLEEKQPKIPN | 741 | Q2NKQ1 | |
| RKENQDGPAPQEEGK | 481 | Q8IUG5 | |
| VEAKEKQDEQVGLPG | 1181 | P11388 | |
| EVDRAKEKGIGTPQP | 26 | Q9Y6X8 | |
| VRNPKGEVVEGDPDK | 401 | O43615 | |
| IIQAPQKEVGKGRDP | 816 | Q641Q2 | |
| RNPERELGDPGEKQK | 136 | Q9Y2Y4 | |
| ELGDPGEKQKPEQVS | 141 | Q9Y2Y4 | |
| PVPTLGKGGQEAEEK | 561 | Q9H8Y1 | |
| GAPEKLPEAKEQAEG | 1266 | P08575 | |
| QKEEGKSQGDPQPEA | 571 | Q702N8 | |
| NRQKKEGEEQPVLPE | 2116 | O95071 | |
| PEKASRPVQEQGGAK | 601 | Q9Y6Q6 | |
| ANPGPLNKDKGEKEE | 91 | P0DV75 |